A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Oct. 28, 2022 United States • Total Cases: 97,329,787 21-Day average: 37 (-25.1%) • Total Deaths: 1,066,351 21-Day average: 373 (-13.7%) • Total new hospital admissions: 5,445,602 7-Day average 3,217 (+1%) Worldwide [Source: WHO] - most recent day • Total Cases: 626,090,018 (267,575 new) • Total Deaths: 6,564,556 (618 new) BQ.1 and BQ.1.1 becoming more prevalent: USA ---------- WHO label Lineage # US Class % Total 95%P1 Omicron BA.S5 VOC 49.6% 45.3-53.9% BO.14 VOC 14.0% 11.2-17.5% BO.1.1 VOC 13.1% 9.8-17.3% BA.4.6 VOC 9.6% 8.6-10.7% BF.? VOC 7.5% 6.6-8.5% BA.5.2.6 VOC 2.8% 2.3-3.5% BA.2.75 VOC 1.8% 1.5-2.2% BA.2.75.2 Voc 12% 0.9-1.6% BA.4 VOC 6.2% 0.2-0.3% BA.2.12.1 Voc 6.0% 0.0-0.0% BA.1.1 VOC 06<.0% 0.0-0.0% BA? VOC 068.0% 0.0-0.0% B.1.1.529 VOC 0.0% 0.0-0.0% Delta B.1.617.2 VBM 0.0% 0.0-0.0% Other Other* 0.0% 0.0-0.1% Amsterdam PRESS: MSNBC with Yasmin Vossoughian; Newsy with Marista Georgiou; Amsterdam News (New York) Heather Butts;V-103 (Atlanta) Interviewer: Maria Boynton; CNN with Jake Tapper;
-
Oct. 30, 2022 On "Meet the Press" this AM (Sunday) Chuck Todd discussed the attack on Paul Pelosi and mentioned several prominent people in Congress and Supreme Court who were also threatened and mentioned the arrest of the person who threatened me and my family
-
Oct. 31, 2022 PRESS: ITV News - UK with Alex Sandler; Wired with Steven Levy;
-
Nov. 1, 2022 Met with Josh Levy today (via Zoom) and with his staff in person (Connie and Pang) to start making arrangement to give my papers and other material such as honorary doctorates to the Library of Congress. Percent reduction with nirmatrelvir/ritonavir versus placebo' a 82% All-causality Oxygen support deaths 100% { 86% q ICU admissions COVID-19---related hospitalizations u 100% Mechanical 89% ventilation { Mean days hospitalized per 100 participants OO OOOO u Y 100% Not discharged 73% Any COVID-19 to home* medical visit * Among hospitalized participants with known discharge status, 100% of those who received nirmatrelvir/ritonavir were discharged to home self-care = Pfizer Third Quarter 2022 Earnings Paxlovid saves lives: PRESS: CBS News interview with Michelle Miller (in anticipation of the Mohammed Ali Award; Diane Rehm podcast;
-
2022-11-01 00:00
Anthony S. Fauci
NOV. 1, 2022 1:15 PM P BQ.1 and BQ.1.1 continues to overcome BA4/5: ally mobbed for selfies. Interesting that hat I might not be well-received and I ih School in Lebanon. PRESS: CBC TV "Rosemary Barton Live";
-
Nov. 2, 2022 9-19 deaths Cases sp. admits Deaths reported* ositivity* Key Metrics Total to date 97,338,600 5,462,578 1,068,470 974,670,768 9.5% 7-day daily average 37,987 3,301 360,528** Week-on-week change +1.9% +1.0% +25.4% -8.8%** +1.1 pct. pts. ne if GOP tkes Published November 1, 2022 at 11:30 p.m. For 1st time in months, the 7 day average numbers are creeping up: PRESS: Article in Washington Post today by Roxanne Roberts on my portrait in the National Portrait Gallery; Tape American Cities Rebuilding with Jeff Greenfield; NPR with Rob Stein; Washington Post Podcast with Maggie Pennman;
-
Nov. 3, 2022 Washington Post story this AM indicating that Rand Paul will come after me if GOP tkes over Senate and he becomes chair of wither HELP or Homeland Security: POLITICS Rand Paul says U.S. botched covid. He could soon lead probes of it. The Kentucky Republican, a fierce critic of the pandemic response, is in line to chair Senate health panel if GOP wins control
-
Nov. 3, 2022 Had Tabletop exercise at the EEOB-350 for emergence of new variant. Led by Ashish Jha and Kevin O'Prey. Present was HHS crew (with Becerra virtual) and Denis McDonough (VA). Only 90 minutes. We really did not accomplish much. Some good comments by Denis McDonough. Am starting to feel the reality of the fact that I am leaving for good in about 7 weeks. A lot of clearing out to do in my office. PRESS: ABC (Local) WJLA TV - "Government Matters" with Mimi Geerges; Canadian Broadcasting Company (CBC) The National News Program (Exit interview) with Adrienne Arsenault; Al Jazeera TV; News Radio 849 WHAS (Kentucky News Station)
-
Nov. 4, 2022 I received the call today from David Ho who had recently published a preprint article showing that the neutralizing antibody response against the BA4/5 variant induced by the bivalent BA 4/5 boost versus the ancestral strain boost were essentially equivalent, namely, the BA4/5 bivalent boost was no better than the standard boost. Last night, I heard from Pfizer in a zoom call with Jha and all of HHS (Walensky, Murthy, Kessler and my team at NIH) that in their experiments there was a fourfold higher titer associated with the boost by the bivalent BA4/5 compared to the boost with the ancestral strain. Pfizer claims that their study was controlled whereas the studies by Ho and Barouch were not and the numbers were small. David Ho called me today and emphasized that the combination of numbers of his study and Barouch's study made them equivalent in size to the Pfizer numbers. In addition, he made the important point that there were some discrepancies in the data that were in the press release from Pfizer which did not contain all of the data that made them concerned about the Pfizer data. In addition, David suggested that it is in Peter Mark's interest to agree with Pfizer since Pfizer confirms what his decision was about the BA4/5 bivalent boost. I do not know whether this is David Ho concerned that his data are not holding up or whether he has a very good point that Pfizer is not being totally above board with the presentation of their data. I will have to try to figure this out by discussing it with a few other people. I have already discussed it with Cliff Lane and he thinks that both of those studies don't definitively show the answer since they both have weaknesses. Cliff recommends that the data undergo significant statistical analysis. HOWEVER, Eric Topol reviews the different studies: Bivalent BA.5 Booster Neutralizing Antibody Lab Assessments Suthar 'Shi Pfizer Ho -Barouch "Barouch Bivalent vs. BA.5 Compared to Original 4-fold improved 3-fold improved 4-fold improved Pseudovirus Minimal difference Pseudovirus 1.3-fold increase Pseudovirus No difference LA Times: SINESS COLUMNIST Usa WHO label! Lintage # = US Class Total «= SS %4P I Omicren BAS VOC 32% M247 BO.1,1 YOO 168% 168.7-224% BO. 1 WOOD TRS TILE er BA 4 VOU 985% 6.6-10.5% BF? YOO 0% Fai BAS 2.6 WOO 31% 253% BA 2.75 VOD 20% 128% BA P52 VO> 1.0% O0.8-71.7% BAL 4 VOD OF% O247% BA.1,1 VOD O0% O4h0% B.1.1.429 VOC OFf% O0o00% BA? .12.1 VOC O="F% O000% BAS VOC O0% Oe00% Deita 8.16172 VBM OFf% O0-00% Cther 'thane o.1% 0.040, 1% Bivalent vs. BO.1.1 Compared to Original ~10-fold increased (vs 1 booster) Low, but 3-fold GMT Not assessed Not assessed Not assessed Modest ~1.2-fold increase Great put down of the HELP Report in LA Times: Column: ProPublica and Vanity Fair are pushing the COVID lab-leak theory, but their exposé is a train wreck BY MICHAEL HILTZIKBUSINESS COLUMNIST